Day: April 16, 2021

WOBURN, Mass., April 16, 2021 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), provider of cloud-based marketing technology software, announced it has once again been chosen to power the digital strategy for an Irish pharmacy. This is the seventh Irish pharmacy store to choose Celebros, a leading eCommerce site search technology from Bridgeline. The pharmacy is committed to providing a trusted, continuous service to its customers and communities. Started in 2007 with their first local pharmacy, this establishment has since expanded to another four locations. Now, the pharmacy is eager to increase their new online presence with Celebros. The pharmacy was able to see first-hand how much intelligent site search could help their online customers’ journey to checkout. They are convinced that Celebros’ powerful on-site search...

Board member Elias Bakk has purchased 127 Tryg shares at DKK 149.75 for a total amount of DKK 19,018. Attachment20_Transaction statement, Elias Bakk

Bestyrelsesmedlem Elias Bakk har i dag købt 127 Tryg-aktier á 149,75 DKK til en samlet værdi på 19.018 DKK. Vedhæftet fil20_Handelsindberetning, Elias Bakk

EDISON, N.J., April 16, 2021 (GLOBE NEWSWIRE) — StrikeForce Technologies, Inc. (OTC PINK: SFOR), a cyber technology company that reduces the risk of identity theft and data breaches and now cyber security services, today announced the acquisition of Cybersecurity Risk Solutions LLC (CRS), a provider of innovative cyber, privacy and data protection solutions for business and home. “The acquisition is now final with Cybersecurity Risk Solutions LLC (CRS) and we are proud to have them as a subsidiary of StrikeForce. We are now positioned to deliver innovative and comprehensive data protection technology to our customers, new and old,” says Mark Kay, CEO of StrikeForce Technologies, Inc. “As I stated before, this is enhancing our broader portfolio offerings and capabilities, while driving new revenue opportunities through our best-in-class...

Oslo, Norway, 16 April 2021 Vistin Pharma ASA will release its first quarter 2021 results on Friday 23rd of April 2021. Vistin Pharma will host a conference call for all shareholders and interested parties on Friday 23rd of April at 08:30 CET. There will be a Q&A session following the management discussion. The conference call will be held in Norwegian. The first quarter conference call will be available via web and audio through the following access points: Telephone conference:Confirmation Code:…….. 4598958International Dial-In:…….. +44 (0) 2071 928338Norway, Oslo:……………. +47 21563015United States, New York: +1 6467413167 Webcast:https://edge.media-server.com/mmc/p/rso5ngk4 ***** For further information, please contact: Alexander KarlsenCFO+47 97053621alexander.karlsen@vistin.com About...

UPPSALA, SWEDEN – LIDDS publishes Annual Report for 2020 The Annual Report is attached to this press release and alos available on LIDDS website: https://liddspharma.com/investors/#financial-reports. For more information, please contact:Monica Wallter, CEO, LIDDS   +46 (0)737 07 09 22  monica.wallter@liddspharma.com LIDDS AB is required to disclose this information pursuant to Nasdaq First North Growth Market – Rulebook. The information was submitted for publication, through the agency of the aforementioned contact person, on April 16, 2021 at 15:00 CET.  LIDDS AB (publ) is a Swedish-based pharmaceutical company with a unique drug delivery technology NanoZolid®. NanoZolid® is a clinically validated drug development technology and superior in its ability to provide a controlled and sustained release of active drug substances for up to...

KANSAS CITY, Mo., April 16, 2021 (GLOBE NEWSWIRE) — Cerner Corporation (Nasdaq: CERN) today announced it will release its first quarter 2021 earnings results before the market opens Wednesday, May 5th. Following the release, the company will hold a conference call at 8:00 a.m. CT that can be accessed via dial-in or webcast. On the call, Cerner will discuss its results and outlook and answer questions from the investment community. The call may also include discussion of Cerner developments and other material and forward-looking information about business and financial matters. The dial-in number for the conference call is (678) 509-7542; the passcode is Cerner. The company recommends joining the call 15 minutes early for registration. An audio webcast will be available live and archived on Cerner’s website in the Investor Relations...

VANCOUVER and MINNEAPOLIS, April 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today announced that the Tiara Transapical system (“Tiara TA”) will be unable to receive a European CE mark under the current Medical Device Directive regulations (“MDD”) ending on May 26, 2021. The Company is collaborating with its European Notified Body (the “Notified Body”) on potential next steps. Neovasc has been working with its Notified Body for more than a year to obtain a decision on a CE Mark for Tiara TA, including an ongoing exchange of additional information beyond the original submission. The Company has determined that it will be unable to provide the additional information required by the Notified Body, which includes further testing data, before...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES TORONTO, April 16, 2021 (GLOBE NEWSWIRE) — Partners Value Split Corp. (the “Company”) announced today that the underwriters in the Company’s previously announced public offering of Class AA Preferred Shares, Series 12 of the Company (the “Series 12 Preferred Shares”) at a price of $25.00 per share (the “Offering Price”) elected to exercise their over-allotment option in full to purchase additional Series 12 Preferred Shares (the “Over-Allotment Option”). The Over-Allotment Option closed today and resulted in 900,000 Series 12 Preferred Shares being issued at the Offering Price for aggregate gross proceeds of $22.5 million. The Series 12 Preferred Shares carry quarterly fixed cumulative preferential dividends representing a 4.40% annualized yield...